Welcome to the Journal of Emerging Drug Formulation Technologies (JEDFT), a leading platform dedicated to the latest advancements and research in the field of drug formulation and technology. Our journal is committed to disseminating high-quality, peer-reviewed research that explores innovative approaches in the development, design, and delivery of pharmaceutical formulations.
Whether you are a researcher, academician, or industry expert, JEDFT offers valuable insights into the latest trends, challenges, and opportunities in drug formulation. Our journal covers a wide range of topics, including but not limited to:
- Case studies on successful drug formulations
- Novel drug delivery systems
- Nanotechnology in drug formulation
- Advanced pharmaceutical formulations
- Biopharmaceuticals and biosimilars
- Regulatory aspects of drug formulation
- Stability and shelf-life studies
- In vitro and in vivo evaluation of formulations
JOURNAL PARTICULARS
Title : Journal of Emerging Drug Formulation Technologies (JEDFT)
Starting Year : 2024
Editor-in-Chief : Dr. Lih-Ching Hsu
ISSN online: 3065-9574
ISSN Print: 3065-9566
Subject : Pharmacy
Name of the Publisher :JAG Unified International(Independent Publications)
Publication Frequency : Bi-Annually
Language : English
Publishing Model : Open Access
Publication Format : Online & Print
Email Id : editorinchiefjedft@jagunifiedinternational.in
editorinchief@jagunifiedinternational.in
Mobile No : +91 8220487289, +91 7708510977, +1 9082053868
ONLINE PAPER SUBMISSION
SUBSCRIBE US
At JEDFT, we recognize the importance of evolving technologies in shaping the future of drug formulation. Our mission is to provide a forum for scientists, researchers, and industry professionals to share their groundbreaking work, fostering collaboration and knowledge exchange that drives progress in the pharmaceutical sciences.
We invite you to explore our current and archived issues, submit your research, and join us in advancing the science of drug formulation. Together, we can contribute to the development of safer, more effective, and innovative pharmaceutical products that improve patient outcomes globally.
